… and cares for heart conditions possibly related to cancer treatment. Our specialists support your child’s heart and cardiovascular system during and after cancer therapy, and can help determine if any cancer therapies should be avoided because of possible risks …
A malignant fibrous histiocytoma is a type of cancerous tumor that can start in bone or in the soft tissues that connect, support, or surround organs and other body parts.
Medical Director, Thyroid Center; Director, Endocrinology Fellowship Training Program; Senior Associate Physician, Division of Endocrinology
Associate Professor of Pediatrics, Harvard Medical School
Dr. Ari Wassner is Medical Director of the Thyroid Center, Director of the Endocrinology Fellowship Training Program at Boston Children's Hospital, and Associate Professor of Pediatrics at Harvard Medical School...
Read more: "Earlier detection of a malignancy in neurofibromatosis type 1 (NF1)."
… at greater risk of developing a rare, aggressive form of cancer. Diagnosing malignant peripheral nerve sheath tumors (MPNSTs) often comes too late, after the cancer has spread and is difficult to treat. But an … the NFRI at Boston Children’s, published their findings in Cancer Discovery on Jan. 4, 2023. The team collected 95 …
… ahead of print] Tissue factor expressed by circulating cancer cell-derived microparticles drastically increases the … (2014) NETosis: a new factor in tumor progression and cancer-associated thrombosis. Demers M, Wagner DD Semin … [PubMed] Neutrophil extracellular traps: A new link to cancer-associated thrombosis and potential implications for …
… work in the use of stem cell biology to study lung cancer and lung disease. Pediatric high-grade gliomas: … Children’s Hospital, Co-Leader for the Dana-Farber/Harvard Cancer Center Leukemia Program, and a Professor of … study from Boston Children’s. Dana-Farber/Boston Children’s Cancer and Blood Disorders Center recognized for exceptional …